Norepinephrine versus phenylephrine for managing maternal hypotension during cesarean delivery under spinal anesthesia: a meta-analysis of maternal and neonatal outcomes

Norepinephrine or phenylephrine administration to prevent and treat hypotension during spinal anesthesia for cesarean section has been a significant topic of discussion. This meta-analysis aimed to update existing evidence and provide further insights into neonatal and maternal outcomes associated with norepinephrine and phenylephrine. Review of randomized controlled trials (RCTs) was performed to assess the effectiveness of norepinephrine and phenylephrine in managing maternal hypotension during cesarean delivery under spinal anesthesia. Neonatal umbilical cord blood pH and maternal hypotension were the primary outcomes. Based on the analysis of 26 RCTs with 2984 participants, we found no significant difference between the norepinephrine and phenylephrine groups in umbilical artery pH in neonates (mean difference (MD) 0.00; 95% confidence interval (CI) −0.00 to 0.01, p = 0.20). Neonates Apgar scores did not differ between both groups. Norepinephrine was associated with lower incidences of bradycardia (risk ratio (RR) 0.44; 95% CI 0.37 to 0.51, p < 0.001) and reactive hypertension (RR 0.53; 95% CI 0.39 to 0.72, p < 0.001) in parturient women than phenylephrine. In neither group did umbilical cord blood levels of partial pressure of oxygen (PaO2), partial pressure of carbon dioxide (PaCO2) and base excess (BE) levels of neonates differ significantly, nor did maternal hypotension, nausea or vomiting incidence during delivery. For maternal hypotension after spinal anesthesia, norepinephrine and phenylephrine did not significantly differ in neonatal acidemia. Despite similarities to phenylephrine in managing hypotension and maintaining maternal hemodynamic stability, norepinephrine is a promising alternative.

Norepinephrine; Phenylephrine; Maternal hypotension; Caesarean delivery; Spinal anesthesia

[1] Bollag L, Lim G, Sultan P, Habib AS, Landau R, Zakowski M, et al. Society for obstetric anesthesia and perinatology: consensus statement and recommendations for enhanced recovery after cesarean. Anesthesia & Analgesia. 2021; 132: 1362–1377.

[2] Mercier FJ, Augè M, Hoffmann C, Fischer C, Le Gouez A. Maternal hypotension during spinal anesthesia for caesarean delivery. Minerva Anestesiologica. 2013; 79: 62–73.

[3] Kitaguchi M, Ida M, Naito Y, Akasaki Y, Kawaguchi M. Associated factors with umbilical arterial pH after cesarean delivery under spinal anesthesia: a retrospective cohort study. Brazilian Journal of Anesthesiology. 2022; 72: 466–471.

[4] Ffrench-O’Carroll R, Tan T. National survey of vasopressor practices for management of spinal anaesthesia-induced hypotension during caesarean section. International Journal of Obstetric Anesthesia. 2021; 45: 156–157.

[5] Kinsella SM, Carvalho B, Dyer RA, Fernando R, McDonnell N, Mercier FJ, et al. International consensus statement on the management of hypotension with vasopressors during caesarean section under spinal anaesthesia. Anaesthesia. 2018; 73: 71–92.

[6] Noffsinger SR. Evidence-based prevention strategies for the management of spinal anesthesia-induced hypotension in healthy parturients undergoing elective cesarean delivery. The AANA Journal. 2022; 90: 311–316.

[7] Park SK, Park DN, Kim YW, Yoo S, Kim WH, Lim YJ, et al. Colloid coload versus crystalloid coload to prevent maternal hypotension in women receiving prophylactic phenylephrine infusion during caesarean delivery: a randomised controlled trial. International Journal of Obstetric Anesthesia. 2022; 49: 103246.

[8] Ngan Kee WD, Lee SW, Ng FF, Tan PE, Khaw KS. Randomized double-blinded comparison of norepinephrine and phenylephrine for maintenance of blood pressure during spinal anesthesia for cesarean delivery. Anesthesiology. 2015; 122: 736–745.

[9] Huang Q, Wen G, Hai C, Zheng Z, Li Y, Huang Z, Huang B. A height-based dosing algorithm of bupivacaine in spinal anesthesia for decreasing maternal hypotension in cesarean section without prophylactic fluid preloading and vasopressors: a randomized-controlled non-inferiority trial. Frontiers in Medicine. 2022; 9: 858115.

[10] Stewart A, Fernando R, McDonald S, Hignett R, Jones T, Columb M. The dose-dependent effects of phenylephrine for elective cesarean delivery under spinal anesthesia. Anesthesia & Analgesia. 2010; 111: 1230–1237.

[11] Liu P, He H, Zhang SS, Liang Y, Gao ZJ, Yuan H, et al. Comparative efficacy and safety of prophylactic norepinephrine and phenylephrine in spinal anesthesia for cesarean section: a systematic review and meta-analysis with trial sequential analysis. Frontiers in Pharmacology. 2022; 13: 1015325.

[12] Heesen M, Hilber N, Rijs K, Rossaint R, Girard T, Mercier FJ, et al. A systematic review of phenylephrine vs. noradrenaline for the management of hypotension associated with neuraxial anaesthesia in women undergoing caesarean section. Anaesthesia. 2020; 75: 800–808.

[13] Singh PM, Singh NP, Reschke M, Ngan Kee WD, Palanisamy A, Monks DT. Vasopressor drugs for the prevention and treatment of hypotension during neuraxial anaesthesia for Caesarean delivery: a Bayesian network meta-analysis of fetal and maternal outcomes. British Journal of Anaesthesia. 2020; 124: e95–e107.

[14] Mohta M, Bambode N, Chilkoti GT, Agarwal R, Malhotra RK, Batra P. Neonatal outcomes following phenylephrine or norepinephrine for treatment of spinal anaesthesia-induced hypotension at emergency caesarean section in women with fetal compromise: a randomised controlled study. International Journal of Obstetric Anesthesia. 2022; 49: 103247.

[15] Singh A, Jain K, Goel N, Arora A, Kumar P. Neonatal outcomes following prophylactic administration of phenylephrine or noradrenaline in women undergoing scheduled caesarean delivery. European Journal of Anaesthesiology. 2022; 39: 269–276.

[16] Liu T, Cheng Z, Zou S, Xu C, Pan S, Zeng H, et al. Effect of weight-adjusted phenylephrine, norepinephrine, and metaraminol for elective cesarean delivery on neonatal acid-base status: a randomized controlled trial. Drug Design, Development and Therapy. 2022; 16: 3215–3223.

[17] Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. The BMJ. 2021; 372: n160.

[18] Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Medical Research Methodology. 2014; 14: 135.

[19] Vallejo MC, Attaallah AF, Elzamzamy OM, Cifarelli DT, Phelps AL, Hobbs GR, et al. An open-label randomized controlled clinical trial for comparison of continuous phenylephrine versus norepinephrine infusion in prevention of spinal hypotension during cesarean delivery. International Journal of Obstetric Anesthesia. 2017; 29: 18–25.

[20] Hasanin A, Amin S, Refaat S, Habib S, Zayed M, abdelwahab Y, et al. Norepinephrine versus phenylephrine infusion for prophylaxis against post-spinal anaesthesia hypotension during elective caesarean delivery: a randomised controlled trial. Anaesthesia Critical Care & Pain Medicine. 2019; 38: 601–607.

[21] Biricik E, Karacaer F, Ünal İ, Sucu M, Ünlügenç H. The effect of epinephrine for the treatment of spinal-hypotension: comparison with norepinephrine and phenylephrine, clinical trial. Brazilian Journal of Anesthesiology. 2020; 70: 500–507.

[22] Theodoraki K, Hadzilia S, Valsamidis D, Stamatakis E. Prevention of hypotension during elective cesarean section with a fixed-rate norepinephrine infusion versus a fixed-rate phenylephrine infusion. Α double-blinded randomized controlled trial. International Journal of Surgery. 2020; 84: 41–49.

[23] Eskandr AM, Ahmed AM, Bahgat NME. Comparative study among ephedrine, norepinephrine and phenylephrine infusions to prevent spinal hypotension during cesarean section. A randomized controlled double-blind study. Egyptian Journal of Anaesthesia. 2021; 37: 295–301.

[24] Goyal N, Goel K, Luthra N, Grewal A, Taneja A. Comparison of norepinephrine and phenylephrine infusions for maintenance of haemodynamics following subarachnoid block in lower segment caeserean section. Indian Journal of Anaesthesia. 2021; 65: 600–605.

[25] Zhou Y, Yu Y, Chu M, Zhang Y, Yu X, Chen G. Comparison of metaraminol, phenylephrine, and norepinephrine infusion for prevention of hypotension during combined spinal-epidural anaesthesia for elective caesarean section: a three-arm, randomized, double-blind, non-inferiority trial. Drug Design, Development and Therapy. 2022; 16: 117–127.

[26] Singh J, Singh J, Mitra S, Anand L, Goel B, Kaur M. Comparison of prophylactic phenylephrine and norepinephrine infusion on umbilical arterial pH and maternal blood pressure during spinal anaesthesia for caesarean delivery. Indian Journal of Anaesthesia. 2022; 66: S115–S121.

[27] Guo L, Qin R, Ren X, Han C, Xue W, He L, et al. Prophylactic norepinephrine or phenylephrine infusion for bradycardia and post-spinal anaesthesia hypotension in patients with preeclampsia during Caesarean delivery: a randomised controlled trial. British Journal of Anaesthesia. 2022; 128: e305–e307.

[28] Du W, Song Y, Li J, Zhou X, Xu Z, Liu Z. Comparison of prophylactic norepinephrine and phenylephrine infusions during spinal anaesthesia for primary caesarean delivery in twin pregnancies: a randomized double-blinded clinical study. Drug Design, Development and Therapy. 2022; 16: 789–798.

[29] Chen Z, Zhou J, Wan L, Huang H. Norepinephrine versus phenylephrine infusion for preventing postspinal hypotension during cesarean section for twin pregnancy: a double-blinded randomized controlled clinical trial. BMC Anesthesiology. 2022; 22: 17.

[30] Mohta M, Garg A, Chilkoti GT, Malhotra RK. A randomised controlled trial of phenylephrine and noradrenaline boluses for treatment of postspinal hypotension during elective caesarean section. Anaesthesia. 2019; 74: 850–855.

[31] Puthenveettil N, Sivachalam S, Rajan S, Paul J, Kumar L. Comparison of norepinephrine and phenylephrine boluses for the treatment of hypotension during spinal anaesthesia for caesarean section—a randomised controlled trial. Indian Journal of Anaesthesia. 2019; 63: 995–1000.

[32] Sharkey AM, Siddiqui N, Downey K, Ye XY, Guevara J, Carvalho JCA. Comparison of intermittent intravenous boluses of phenylephrine and norepinephrine to prevent and treat spinal-induced hypotension in cesarean deliveries: randomized controlled trial. Anesthesia & Analgesia. 2019; 129: 1312–1318.

[33] Wang X, Mao M, Liu S, Xu S, Yang J. A comparative study of bolus norepinephrine, phenylephrine, and ephedrine for the treatment of maternal hypotension in parturients with preeclampsia during cesarean delivery under spinal anesthesia. Medical Science Monitor. 2019; 25: 1093–1101.

[34] Cho WJ, Cho SY, Lee A. Systemic hemodynamic effects of norepinephrine versus phenylephrine in intermittent bolus doses during spinal anesthesia for cesarean delivery. Anesthesia and Pain Medicine. 2020; 15: 53–60.

[35] Mohta M, R L, Chilkoti GT, Agarwal R, Malhotra RK. A randomised double-blind comparison of phenylephrine and norepinephrine for the management of postspinal hypotension in pre-eclamptic patients undergoing caesarean section. European Journal of Anaesthesiology. 2021; 38: 1077–1084.

[36] Tiwari JP, Verma SJ, Singh AK. A prospective randomized study comparing the bolus doses of norepinephrine and phenylephrine for the treatment of spinal induced hypotension in cesarean section. Cureus. 2022; 14: e27166.

[37] Rai AV, Prakash S, Chellani H, Mullick P, Wason R. Comparison of phenylephrine and norepinephrine for treatment of spinal hypotension during elective cesarean delivery—a randomised, double-blind study. Journal of Anaesthesiology Clinical Pharmacology. 2022; 38: 445–452.

[38] Dong L, Dong Q, Song X, Liu Y, Wang Y. Comparison of prophylactic bolus norepinephrine and phenylephrine on hypotension during spinal anesthesia for cesarean section. International Journal of Clinical and Experimental Medicine. 2017; 10: 12315–12321.

[39] Wang X, Mao M, Zhang SS, Wang ZH, Xu SQ, Shen XF. Bolus norepinephrine and phenylephrine for maternal hypotension during elective cesarean section with spinal anesthesia: a randomized, double-blinded study. Chinese Medical Journal. 2020; 133: 509–516.

[40] Ngan Kee WD, Lee SWY, Ng FF, Lee A. Norepinephrine or phenylephrine during spinal anaesthesia for Caesarean delivery: a randomised double-blind pragmatic non-inferiority study of neonatal outcome. British Journal of Anaesthesia. 2020; 125: 588–595.

[41] Hassanin AS, El-Shahawy HF, Hussain SH, Bahaa Eldin AM, Elhawary MM, Elbakery M, et al. Impact of interval between induction of spinal anesthesia to delivery on umbilical arterial cord pH of neonates delivered by elective cesarean section. BMC Pregnancy and Childbirth. 2022; 22: 216.

[42] Singh S, Lumbreras-Marquez MI, Farber MK, Xu X, Singh P, Gorman T, et al. Transient tachypnea of newborns is associated with maternal spinal hypotension during elective cesarean delivery: a retrospective cohort study. Anesthesia & Analgesia. 2019; 129: 162–167.

[43] Malin GL, Morris RK, Khan KS. Strength of association between umbilical cord pH and perinatal and long term outcomes: systematic review and meta-analysis. The BMJ. 2010; 340: c1471.

[44] Hoberg C, Klein C, Klein D, Meller C. Perinatal hypoxia and the risk of severe Molar-Incisor Hypomineralisation (MIH): a retrospective analysis of the pH value of umbilical arterial blood after birth. European Archives of Paediatric Dentistry. 2022; 23: 109–115.

[45] Heesen M, Klöhr S, Rossaint R, Straube S. Prophylactic phenylephrine for caesarean section under spinal anaesthesia: systematic review and meta-analysis. Anaesthesia. 2014; 69: 143–165.

[46] Liu JP, Pan ZB, Zhu M, Zhu GW, Song DB, Chen XZ, et al. Determination of the 90% effective dose of phenylephrine boluses to treat spinal anesthesia-induced hypotension in patients with severe preeclampsia during cesarean delivery: a pilot study. Drug Design, Development and Therapy. 2021; 15: 3765–3772.

[47] Pauline A, Arthi K, Parameswari A, Vakamudi M, Manickam A. Prophylactic fixed-rate phenylephrine versus norepinephrine infusion in the prevention of post-spinal anesthesia hypotension during cesarean delivery. Cureus. 2023; 15: e41251.

[48] Wang X, Shen X, Liu S, Yang J, Xu S. The efficacy and safety of norepinephrine and its feasibility as a replacement for phenylephrine to manage maternal hypotension during elective cesarean delivery under spinal anesthesia. BioMed Research International. 2018; 2018: 1869189.